AHI (Anastrozole 1 mg)

Pill imprint AHI has been identified as Anastrozole 1 mg.

Anastrozole is used in the treatment of breast cancer; breast cancer, metastatic; pubertal gynecomastia; endometrial cancer; mccune-albright syndrome and belongs to the drug classes aromatase inhibitors, hormones/antineoplastics. There is positive evidence of human fetal risk during pregnancy. Anastrozole 1 mg is not subject to the Controlled Substances Act.

See also related documents.

Images for AHI (Anastrozole 1 mg)

Anastrozole 1 mg AHI
Anastrozole
Imprint:
AHI
Strength:
1 mg
Color:
White
Shape:
Round
Availability:
Prescription only
Drug Class:
Aromatase inhibitors
Hormones/antineoplastics
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Accord Healthcare
National Drug Code (NDC):
16729-0035
Inactive Ingredients:
lactose
magnesium stearate
hypromelloses
polyethylene glycol
povidone
sodium starch glycolate type A potato
titanium dioxide

View Details Print Page

Pill Identifier

Search by Imprint, Shape or Color

Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

Search by Drug Name

Search by National Drug Codes (NDC)

Advanced Breast Cancer: Learn about treatments to improve quality of life. Click Here

Close
Hide
(web4)